-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse NasdaqISIN US45249V1070
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
244.399.888 oder 116.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
16 oder 6 Mitarbeiter
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 7,83 USD +2,08%
Portrait der Imara Aktie
Das Unternehmen IMARA Inc aus USA beschäftigt 11 Mitarbeiter.
Dir gefallen die Informationen zu Imara?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Imara?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Imara?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Imara?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
22 News & Informationen zur Imara Aktie
Imara Reports Second Quarter 2021 Financial Results and Business Highlights
Accelerated enrollment in Phase 2b trials in sickle cell disease and beta-thalassemia; interim analyses expected in fourth quarter of 2021 Positive IMR-687 data in sickle cell disease… | August 6, 2021
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell
• Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of …
Imara Inc. $IMRA insider buying : stocks
Any ideas on Imara inc? Just found this article regarding insider trading: … IMARA, a clinical stage biopharmaceutical firm, engaged in research …
Imara to Webcast Conference Call of Second Quarter 2021 Financial Results and Business Highlights
BOSTON, July 30, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and…
5 Potential Meme Stocks That Could Be the Next BIG Thing
There has been a revolution in stocks this year! Find out the meme stocks that could potentially become the next big hit in the stock market.
The Past Week's Notable Insider Buys Include Ring Energy, SentinelOne, SPACs And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Special purpose acquisition…
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…
Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge
Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to …
Imara Announces Pricing Of Public Offering
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and
Biotech Losers In 2021 That Could Bounce Big In The Second Half
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary …
Imara Announces Appointment Of Laura A. Williams, M.D., MPH To Board Of Directors
BOSTON, June 30, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing
Should I Avoid Lyra Therapeutics, Inc. (LYRA)?
In this article we will take a look at whether hedge funds think Lyra Therapeutics, Inc. (NASDAQ:LYRA) is a good investment right now. We check hedge…
Hedge Fund Sentiment Is Stagnant On IMARA Inc. (IMRA)
In this article we will analyze whether IMARA Inc. (NASDAQ:IMRA) is a good investment right now by following the lead of some of the best investors in…
Where Do Hedge Funds Stand On Colony Bankcorp Inc (CBAN)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors…
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 1 company set new 52-week lows.
The following stock set new 52-week lows as of 10 a.m. ET on Friday: Imara …
Imara Analyst Says Buy The Weakness Ahead Of Multiple 2021 Data Readouts
Imara Inc (NASDAQ:IMRA) shares took a thrashing Wednesday following the release of mid-stage results of its IMR-687 in sickle cell disease. Under…
Imara Analyst Says Buy The Weakness Ahead Of Multiple 2021 Data Readouts
Imara Inc (NASDAQ: IMRA) shares took a thrashing Wednesday following the release of mid-stage results of its IMR-687 in sickle cell disease.
Underwhelming …
Mid-Afternoon Market Update: Dow Surges Over 600 Points; Imara Shares Plunge
Toward the end of trading Wednesday, the Dow traded up 2.02% to 31,005.69 while the NASDAQ rose 0.61% to 12,897.65. The S&P also rose, gaining 1.46% to …
Mid-Day Market Update: Gold Down Over 2%; Change Healthcare Shares Jump
Midway through trading Wednesday, the Dow traded up 1.63% to 30,886.85 while the NASDAQ rose 0.53% to 12,886.46. The S&P also rose, gaining 1.17% to …
Mid-Morning Market Update: Markets Open Higher; RPM International Earnings Top Views
Following the market opening Wednesday, the Dow traded up 1.34% to 30,797.88 while the NASDAQ rose 0.02% to 12,820.97. The S&P also rose, gaining 0.81% …
Arix Bioscience : Imara reports Phase 2a clinical trial results of -2-
Biomarker results in IMR-687+HU treated patients showed an overall increase
in F-cells and HbF levels from baseline to week 24, while Hb levels did not
meaningfully change. Three of the eight… | January 6, 2021
Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease
Promising reductions in rate of VOCs/SCPCs observed in monotherapy IMR-687 treated patients vs. placebo
Biomarker data from both monotherapy IMR-687 and …